Stefano Piatto Clerici

Stefano Piatto Clerici

Auto-generated profile, based on publicly available information

Stefano Piatto Clerici

Department of Biochemistry and Tissue Biology University of Campinas, UNICAMP Campinas São Paulo Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
POPatricia F. de Souza Oliveira
Patricia F. de Souza Oliveira
AFAlessandra Faria
Alessandra Faria
SCStefano P. Clerici
Stefano P. Clerici
EAErica M. Akagi
Erica M. Akagi
Hernandes CarvalhoHernandes Carvalho
Hernandes Carvalho
CFCarmen V. Ferreira-Halder
Carmen V. Ferreira-Halder

3 December 2021 in Biological Chemistry
Verified
Journal Article
Closed access
KRKarin J. P. Rocha-Brito
Karin J. P. Rocha-Brito
SCStefano Piatto Clerici
Stefano Piatto Clerici
HCHelon Guimarães Cordeiro
Helon Guimarães Cordeiro
AFAmanda Petrina Scotá Ferreira
Amanda Petrina Scotá Ferreira
EFEmanuella Maria Barreto Fonseca
Emanuella Maria Barreto Fonseca
CFCarmen V. Ferreira-Halder
Carmen V. Ferreira-Halder
Melanoma is a type of skin cancer with low survival rates after it has metastasized. In order to find molecular differences that could represent targets of quercetin in anti-melanoma activity, we have chosen SKMEL-103 and SKMEL-28 melanoma cells and human melanocytes as models. Firstly, we observed that quercetin was able in reducing SKMEL-103 cell viability, but not in SKMEL-28. Besides that, quercetin treatment caused inhibition of AXL in both cell lines, but upregulation of PIM-1 in SKMEL-28 and downregulation in SKMEL-103. Moreover, HIF-1 alpha expression decreased in both cell lines. Interestingly, quercetin was more effective against SKMEL-103 than kinases inhibitors, such as Imatinib, Temsirolimus, U0126, and Erlotinib. Interestingly, we observed that while the levels of succinate dehydrogenase and voltage-dependent anion channel increased in SKMEL-103, both proteins were downregulated in SKMEL-28 after quercetin’s treatment. Furthermore, AKT, AXL, PIM-1, ABL kinases were much more active and chaperones HSP90, HSP70 and GAPDH were highly expressed in SKMEL-103 cells in comparison with melanocytes. Our findings indicate, for the first time, that the efficacy of quercetin to kill melanoma cells depends on its ability in inhibiting tyrosine kinase and upregulating mitochondrial proteins, at least when SKMEL-103 and SKMEL-28 cells response were compared.

4 February 2021 in Biological Chemistry
Verified
Journal Article
Closed access
SCStefano Piatto Clerici
Stefano Piatto Clerici
POPatrícia Fernandes de Souza Oliveira
Patrícia Fernandes de Souza Oliveira
EAErica Mie Akagi
Erica Mie Akagi
HCHelon Guimarães Cordeiro
Helon Guimarães Cordeiro
JAJordana Maria Azevedo-Martins
Jordana Maria Azevedo-Martins
CFCarmen V. Ferreira-Halder
Carmen V. Ferreira-Halder
The main post-translational reversible modulation of proteins is phosphorylation and dephosphorylation, catalyzed by protein kinases (PKs) and protein phosphatases (PPs) which is crucial for homeostasis. Imbalance in this crosstalk can be related to diseases, including cancer. Plenty of evidence indicates that protein tyrosine phosphatases (PTPs) can act as tumor suppressors and tumor promoters. In gastric cancer (GC), there is a lack of understanding of the molecular aspects behind the tumoral onset and progression. Here we describe several members of the PTP family related to gastric carcinogenesis. We discuss the associated molecular mechanisms which support the down or up modulation of different PTPs. We emphasize the Helicobacter pylori ( H. pylori ) virulence which is in part associated with the activation of PTP receptors. We also explore the involvement of intracellular redox state in response to H. pylori infection. In addition, some PTP members are under influence by genetic mutations, epigenetics mechanisms, and miRNA modulation. The understanding of multiple aspects of PTPs in GC may provide new targets and perspectives on drug development.


13 November 2026 in Tissue and Cell
Verified
Journal Article
Open access
SCStefano Piatto Clerici
Stefano Piatto Clerici
GFGwenny Fuhler
Gwenny Fuhler
MPMaikel Peppelenbosch
Maikel Peppelenbosch
CFCélio Junior da Costa Fernandes
Célio Junior da Costa Fernandes